ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Private Advisor Group LLC

Private Advisor Group LLC lowered its position in ARK Genomic Revolution ETF (BATS:ARKG) by 37.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,243 shares of the company’s stock after selling 16,614 shares during the quarter. Private Advisor Group LLC’s holdings in ARK Genomic Revolution ETF were worth $697,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. EverSource Wealth Advisors LLC purchased a new stake in ARK Genomic Revolution ETF in the 1st quarter valued at approximately $49,000. Cetera Investment Advisers lifted its position in shares of ARK Genomic Revolution ETF by 290.7% in the first quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock valued at $4,052,000 after acquiring an additional 104,831 shares in the last quarter. Janney Montgomery Scott LLC boosted its stake in shares of ARK Genomic Revolution ETF by 14.2% during the first quarter. Janney Montgomery Scott LLC now owns 8,425 shares of the company’s stock valued at $242,000 after acquiring an additional 1,045 shares during the last quarter. CWM LLC increased its position in ARK Genomic Revolution ETF by 7.7% during the 2nd quarter. CWM LLC now owns 48,260 shares of the company’s stock worth $1,133,000 after purchasing an additional 3,432 shares in the last quarter. Finally, SG Americas Securities LLC raised its stake in ARK Genomic Revolution ETF by 5.4% in the 2nd quarter. SG Americas Securities LLC now owns 129,356 shares of the company’s stock valued at $3,037,000 after purchasing an additional 6,675 shares during the last quarter.

ARK Genomic Revolution ETF Stock Performance

BATS:ARKG opened at $24.00 on Monday. The company has a 50-day moving average price of $25.04 and a 200-day moving average price of $25.06.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.